Advertisement
Singapore markets open in 7 hours 8 minutes

  • Straits Times Index

    3,439.88
    +24.37 (+0.71%)
     

  • S&P 500

    5,537.02
    +28.01 (+0.51%)
     

  • Dow

    39,308.00
    -23.90 (-0.06%)
     

  • Nasdaq

    18,188.30
    +159.54 (+0.88%)
     

  • Bitcoin USD

    58,106.88
    -2,076.90 (-3.45%)
     

  • CMC Crypto 200

    1,214.81
    -46.38 (-3.68%)
     

  • FTSE 100

    8,241.26
    +70.14 (+0.86%)
     

  • Gold

    2,369.40
    0.00 (0.00%)
     

  • Crude Oil

    84.15
    +0.27 (+0.32%)
     

  • 10-Yr Bond

    4.3550
    0.0000 (0.00%)
     

  • Nikkei

    40,913.65
    +332.89 (+0.82%)
     

  • Hang Seng

    18,028.28
    +49.71 (+0.28%)
     

  • FTSE Bursa Malaysia

    1,616.75
    +1.43 (+0.09%)
     

  • Jakarta Composite Index

    7,220.89
    +24.13 (+0.34%)
     

  • PSE Index

    6,507.49
    +57.46 (+0.89%)
     

Eli Lilly history: Beyond the Ticker

Anjalee Khemlani and Yahoo Finance

With a rich history dating back to the 19th century, Eli Lilly (LLY) has faced struggles and successes. But a booming market cap has quickly turned it into the biggest pharmaceutical brand in the world.

Let's dive into Lilly’s biggest moments with Beyond the Ticker.

1876

The company was founded by Colonel Eli Lilly, a pharmaceutical chemist and Union Army veteran. Lilly served as the company president until he died in 1898.

1914-1918

Lilly experienced huge growth before and after World War I, including the expansion of its Indianapolis, Indiana, facility.

1923

The company began selling Iletin to treat diabetes, the world's first commercially available insulin product.

ADVERTISEMENT

1952

Lilly became a publicly traded company on the New York Stock Exchange.

1971

Lilly acquired cosmetic manufacturer Elizabeth Arden for $38 million, eventually turning it into a financial success.

1987

Lilly sold Arden to Fabergé for $657 million.

2009

A fine of over $1.4 billion, the largest in US history, was imposed on Lilly for illegally marketing its best-selling mood disorder product Zyprexa.

2022

Lilly hit the jackpot with tirzepatide, a new type of GLP-1 product, sold as Mounjaro for type II diabetes. It began competing with Novo Nordisk’s (NVO) Ozempic, which had been on the market for a few years, but started struggling to meet demand as its popularity grew for off label weight loss use.

2023

Zepbound, the same formula as Mounjaro, was approved for obesity, and it began competing with Novo’s Wegovy.

The two companies have a duopoly in this brand-new obesity market. The tirzepatide drugs have spiked Lilly’s stock by nearly 100% in the past year, and its annual revenue was over $34.1 billion in 2023 – a nearly 20% increase year-over-year.

2024

Lilly continues to reach all-time highs and is currently the biggest healthcare company in the world, with a market cap of well over $800 billion.

Wall Street projects the GLP-1s alone will net Lilly $13 billion this year. And this is all before the FDA expands their use for other diseases. Its why Lilly is on track to make history and be the first trillion dollar healthcare company.

From tech giants to retail titans, Beyond the Ticker is a historical series that takes a deep dive into some of Wall Street's trending companies and how they transformed into the financial icons they are today.

Check out more of our Beyond the Ticker series, and be sure to tune in to Yahoo Finance.

Editor's note: This video was produced by Zach Faulds.

Video transcript

With a rich history.

Dating back to the 19th century, Eli Lilly has faced struggles and successes, but a booming market cap has quickly turned it into the biggest pharmaceutical brand in the world.

Let's dive into Lily's biggest moments was beyond the ticker.

The company was founded in 1876 by Colonel Eli Lilly, a pharmaceutical chemist, and union army veteran Lily experienced huge growth before and after world war one, including the expansion of its Indianapolis facility.

In 19 23 the company began selling iIn to treat diabetes, the world's first commercial insulin product.

Then in 1952 Lily became a publicly traded company on the New York Stock Exchange.

In 1971 Lily acquired cosmetic brand Elizabeth Arden for $38 million.

Eventually turning it into a financial success.

It sold Arden to Faberge for $657 million in 1987.

Fast forward to 2009 when Lily faced a fine of over $1.4 billion the largest in us history for illegally marketing its Blockbuster mood disorder drug Zyprexa.

It wasn't until 2022 that Lily hit the jackpot with T Zit a new type of G LP one product sold as Mano for type two diabetes.

It began competing with Novo nodus Ozempic zep bound.

The same formula as Manja was approved for obesity in 2023 and began competing with Novos Wigo.

The appetite drugs have spiked Lily's stock by nearly 100% in the past year.

In 2024 Lily continues to reach all time highs and is currently the biggest health care company in the world with a market cap of well over $800 billion Wall Street projects.

The G LP one S alone will net Lily $13 billion this year.

It's why Lily is on track to make history as the first trillion dollar health care company.